adefovir dipivoxil has been researched along with Cancer of Colon in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, QY; Hong, P; Hu, HF; Huang, XH; Li, B; Xu, WW; Yan, X; Yang, J; Ye, F; Zhang, QH | 1 |
1 other study(ies) available for adefovir dipivoxil and Cancer of Colon
| Article | Year |
|---|---|
Adefovir dipivoxil sensitizes colon cancer cells to vemurafenib by disrupting the KCTD12-CDK1 interaction.
Topics: Adenine; Antineoplastic Agents; CDC2 Protein Kinase; Cell Line, Tumor; Colonic Neoplasms; Humans; Organophosphonates; Protein Binding; Proteins; Reverse Transcriptase Inhibitors; Vemurafenib | 2019 |